Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 1373

Emailed: 0

PDF Downloaded: 2121


Singh, Kaur, Meena, Saraya, Kaur, and Singh: Smoking index- A measure to quantify cumulative smoking exposure


Introduction

Nearly 3% of the adult population was found to have an unruptured intracranial aneurysm (IA).1 With the increasing use of cranial imaging, more incidental IAs is being detected in clinical practice. Although the annual risk of rupture of asymptomatic IA is relatively low, subarachnoid hemorrhage (SAH) caused by IA rupture associated with high rates of morbidity and mortality.2 Prevention is better than cure. Hence, to prevent SAH via modifiable risk factors identification and management, rather than surgical clipping and intravascular intervention, is of great clinical and social value. Smoking is the most important established risk factor for IA rupture,3, 4, 5, 6 and up to 80% of patients who sustain an aneurysmal SAH have a history of smoking, and 50–60% are current smokers.7, 8 A Finnish register-based study reported that the incidence of SAH was decreasing and this trend may be associated with changes in smoking rates, suggesting the possible benefits of smoking cessation.9 However, the predictors of adverse outcome after smoking exposure have not been clearly identified, and most studies have simply stratified subjects based on the presence or absence of a history of cigarette smoking.7, 8 Using quantitative indicators within the smoking history, such as the number of cigarettes smoked per day (CPD) and smoking index (CPD × years of tobacco use),10 may lead to a more detailed understanding of the mechanisms by which smoking contributes to aneurysm formation and rupture and helps to develop strategies to reduce the risk of rupture. We, therefore, devised a case–control study to investigate the effect of smoking on the risk of IA rupture, specifically the relationship between the CPD and smoking index and rupture risk.

Patient selection

We performed a single-center case–control study of consecutive patients evaluated or treated for IA at our institution from June 2017 to July 2018. Cases were defined as patients with SAH secondary to a ruptured IA and controls as patients harboring a UIA. Two controls were randomly selected from the patients admitted with a diagnosis of UIA and matched to each case based on age (±5 years) and sex. All enrolled patients were examined using three-dimensional rotational an giography. For all cases, SAH was diagnosed using computed tomography (CT).

Our exclusion criteria included

(1) dissecting, fusiform, traumatic, mycotic, or partially thrombosed aneurysms; (2) the patients with nonaneurysmal SAH examinated by digital subtraction angiography (DSA), or the location of ruptured aneurysm could not be identified among multiple IAs by CT and DSA; (3) aneurysms without clear and readable three-dimensional rotational angiography that allowed an evaluation of lesion geometry and morphology; (4) aneurysms associated with cerebral arteriovenous malformation, arteriovenous fistula, or moyamoya disease. The study was approved by the review committee of our hospital, and informed consent was obtained from all the subjects.

Data collection and definitions

Information on smoking was obtained from the medical history recorded by the treating physicians during interviews of patients or family members. If the patient’s information was incomplete, we obtained information using a telephone survey. All patients were asked “Have you ever smoked?” and if the answer was yes, “For how many years in total have you smoked?”, “how long ago did you quit smoking?”, and “Do you currently smoke?” Individuals who were current smokers or former smokers were asked to report the mean number of cigarettes, pipes, and cigars smoked per day. Nonsmokers affirmed that they had never smoked or smoked <100 cigarettes (lifetime). Patients who smoked at the time of treatment or smoked ≥100 cigarettes during the past year were considered current smokers. Patients who had smoked ≥100 cigarettes but had not smoked during the past year were considered former smokers.10 The smoking index is a unit for measuring cigarettes consumption over a long period and was calculated using the following formula: smoking index = CPD × years of tobacco use. Smoking index categories were nonsmoker, <400, 400–799, and ≥800.11 The CPD was estimated for current and former smokers. We defined heavy smoking as ≥20 CPD and mild smoking as <20 CPD.12 We investigated other potential risk factors for aneurismal rupture. Social-demographic characteristics included age, sex, and educational level, and clinical characteristics included body mass index (BMI), comorbidities, coronary artery procedures, alcohol use (current or previous intake >5 drinks per day), and family history of IA. A BMI ≥25 kg/m2was defined as overweight.13 All morphological parameters were obtained by three-dimensional rotational angiography and evaluated by two experienced neurosurgeons.

Statistical analyses

All statistical analyses were performed using SPSS Statistics for Windows (Version 22.0; IBM Corp., Armonk, New York, USA). Continuous variables were analyzed using the Mann–Whitney U test or Student’s t-test and are presented as mean ± SD or medians (interquartile ranges). Categorical variables were analyzed using Fisher’s exact test or the Pearson chi-square test and are presented as frequencies (percentages). Associations between smoking history and intracranial aneurysm rupture (IAR) were assessed using Fisher’s exact test or the linear-by-linear association test. Because our study was performed on a matched sample, the Cochran–Mantel–Haenszel test was also performed. As predetermined, variables with a P < 0.20 in the univariate logistic regression analysis were evaluated in our multivariate analysis. Because the sample was matched, we used conditional logistic regression to calculate univariate and multivariate odds ratios (ORs) with 95% confidence intervals (CI). A P-value <0.05 was regarded as statistically significant.

Results

A total of 1000 patients with IAs were evaluated or treated at our institution during the study period. After applying our exclusion criteria, 300 case of IAR and 680 cases of unruptured IAs were included. However, 20 cases of ruptured IAs failed to find their matched controls. Consequently, our study population was composed of 127 cases of IAR and 254 matched controls with UIAs

The frequency and odds of risk factors in IAR cases compared to controls. The following covariates met our previously determined level of significance and entered the stepwise forward selection for the conditional logistic model: smoking status (nonsmoking, former smoking, and current smoking; P  with significant p value), BMI ≥ 25 (P >0.05), alcohol use (P <0.05), history of hyperlipidemia (P <0.05), diabetes mellitus (P <0.05), aneurysm size (P <0.05).

Cases and controls also showed significant differences in frequency and risk of IAR based on smoking status determined by CPD [nonsmoker, former smoker, mild current smoking (CPD <20), and heavy current smoking (CPD ≥20); P<0.05] and smoking index (nonsmoker, former smoker, and current smoker with smoking indexes of <400, 400–799, and ≥800, respectively; P <0.05).

Discussion

In this case–control study, we demonstrated that a CPD ≥20 and a high smoking index were strong risk factors for IAR. Furthermore, compared with former smokers who had quit at least 1 year before evaluation, current smokers were more predisposed to IAR, suggesting the importance of smoking cessation in patients with an IA.

Similarly, in their case–control study of 250 patients with an aneurysmal SAH and 206 patients with a UIA, Monique et al. found that current smoking increased the risk of IAR.7 One possible explanation is that most smoking-induced changes are reversible after quitting, although previous studies suggested that former smokers demonstrate an ongoing low-grade inflammatory response that persists long after smoking cessation.14 Cigarette smoke is an aerosol containing thousands of chemicals, including nicotine, carbon monoxide, and oxidant compounds,14 and chronic exposure induces multiple pathological effects in the vascular endothelium and facilitates inflammation. This process consistently weakens the UIA wall making it more vulnerable to trigger factors and eventually leads to rupture. Aneurysm growth has also been shown to be increased by current smoking supporting the concept that smoking increases SAH particularly by increasing aneurysm size and possibility of rupture.15, 16 Although the CPD was a strong and independent risk factor for UIAs in our study, it should be noted that this straightforward index of cumulative exposure does not take the duration of smoking into account. Therefore, we used the smoking index to investigate whether the increased risk of IAR due to smoking is modifiable. This index can make strong assumptions regarding the equivalence of the roles of intensity and duration.17 We found a significant association between the smoking index and the risk of IAR. Our results are congruent with the basic research findings that the effects of cigarette smoke on endothelial cells are only functional initially, while the endothelial-cell layer exhibits physical damage and can even be completely destroyed by chronic exposure of cigarette smoke (increase of smoking index).18 Moreover, increasing degrees of smoking may be more permissive to accelerate morphological changes of aneurysms.19 These changes, in turn, may increase the eventual rupture risk of the aneurysm. We confirmed this association using a conditional logistic regression model. However, the association between a smoking index of 400–799 and the risk of IAR did not reach statistical significance in our study. This result may be due to our retrospective study design and limited sample size.

In our study, 73.2% of ruptured aneurysms were in a bifurcation location, and this location was an independent risk factor that raised the risk of IAR by a factor of 10.972. This finding is consistent with previous reports.17 The arterial wall is consistently weakened, where it bifurcates because this area correlates with increased hemodynamic stress and higher blood flow. Thus, IAs in bifurcation locations have a higher risk of rupture than those in other locations.20 What is more, we analyzed the risk for IAR of bifurcation location among smokers (current smoking/former smoker) and nonsmokers, respectively. Our results showed that the bifurcation risk increased for smokers and nonsmokers.

The risk of IAR in female smokers might be greater than the rupture risk in male smokers. This hypothesis is supported by several studies reporting a dramatic sex-based difference in risk at a given level of cigarette consumption.20, 21 In their community-based case–control analysis, Bonita et al. demonstrated that cigarette smokers had a significantly increased risk of SAH compared with nonsmokers with relative risks of 3.0 and 4.7 for men and women, respectively.20 Age is an important independent risk factor for acute aneurysm rupture,22, 21 and one of the most important factors affecting cigarette consumption duration. We matched cases based on year of birth (age ± 5 years) and sex to avoid introducing variability.

Our study showed that hyperlipidemia independently decreased the risk of IAR. Recently, several studies reported similar results.5, 17 Interestingly, a recent study reported an association between the administration of statins and reduced UIA formation in rats.17 It may be that hypercholesterolemic patients treated with statins gain a similar protective benefit. BMI also independently decreased the risk of IAR, a finding similar to that reported by Monique et al.5 In their study of 305 patients with SAH, Hughes et al. reported that BMI was inversely related to short- and long-term mortality.23 However, few other studies demonstrating an association between BMI and aneurysm rupture are available. We also found that diabetes mellitus was associated with a decreased risk of IAR. It has been hypothesized that many patients had presented for evaluation of their diabetes mellitus, allowing some IAs to be diagnosed before they ruptured or altering lifestyle factors and continuing medical care to reduce the risk of SAH. However, the biological foundation of this inverse correlation needs further investigation.

Conclusion

Patients with IA who smoked had a greater risk of aneurysm rupture compared with those who were nonsmokers or former smokers. The strength of the association between current smoking and the risk of aneurysmal rupture was directly related to the smoking index and CPD. Information from the current study may be beneficial to increase the potential for patients harboring IAs to quit or reduce smoking prior to life-threatening SAH.

Source of Funding

None.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1 

Vijay M. Ravindra Adam de Havenon Timothy C. Gooldy Jonathan Scoville Jian Guan William T. Couldwell Validation of the unruptured intracranial aneurysm treatment score: comparison with real-world cerebrovascular practiceJ Neurosurg2018129110060022-3085, 1933-0693Journal of Neurosurgery Publishing Group (JNSPG)

2 

R Loch Macdonald Tom A Schweizer Spontaneous subarachnoid haemorrhageLancet201738910069655660140-6736Elsevier BV

3 

Seppo Juvela Miikka Korja Intracranial Aneurysm Parameters for Predicting a Future Subarachnoid Hemorrhage: A Long-Term Follow-up StudyNeurosurg2017813432400148-396X, 1524-4040Oxford University Press (OUP)

4 

Rachel Kleinloog Nikki de Mul Bon H Verweij Jan Andries Post Gabriel J E Rinkel Ynte M Ruigrok Risk Factors for Intracranial Aneurysm Rupture: A Systematic ReviewNeurosurg2018824431400148-396X, 1524-4040Oxford University Press (OUP)

5 

Anil Can Victor M. Castro Yildirim H. Ozdemir Sarajune Dagen Sheng Yu Dmitriy Dligach Association of intracranial aneurysm rupture with smoking duration, intensity, and cessationNeurol201789131408150028-3878, 1526-632XOvid Technologies (Wolters Kluwer Health)

6 

J. Pablo Villablanca Gary R. Duckwiler Reza Jahan Satoshi Tateshima Neil A. Martin John Frazee Natural History of Asymptomatic Unruptured Cerebral Aneurysms Evaluated at CT Angiography: Growth and Rupture Incidence and Correlation with Epidemiologic Risk FactorsRadiol20132691258650033-8419, 1527-1315Radiological Society of North America (RSNA)

7 

Monique H.M. Vlak Gabriel J.E. Rinkel Paut Greebe Ale Algra Risk of Rupture of an Intracranial Aneurysm Based on Patient CharacteristicsStroke2013443231

8 

D. Woo J. Khoury M. M. Haverbusch P. Sekar M. L. Flaherty D. O. Kleindorfer Smoking and family history and risk of aneurysmal subarachnoid hemorrhageNeurol200972169720028-3878, 1526-632XOvid Technologies (Wolters Kluwer Health)

9 

Miikka Korja Hanna Lehto Seppo Juvela Jaakko Kaprio Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking ratesNeurol201687111118230028-3878, 1526-632XOvid Technologies (Wolters Kluwer Health)

10 

Sandra I. Sulsky William G. Fuller Cynthia Van Landingham Michael W. Ogden James E. Swauger Geoffrey M. Curtin Evaluating the association between menthol cigarette use and the likelihood of being a former versus current smokerRegul Toxicol Pharmacol2014701231410273-2300Elsevier BV

11 

Naoyoshi Nagata Ryota Niikura Takuro Shimbo Yoshihiro Kishida Katsunori Sekine Shohei Tanaka Alcohol and Smoking Affect Risk of Uncomplicated Colonic Diverticulosis in JapanPLoS ONE2013812e811371932-6203Public Library of Science (PLoS)

12 

Salma M. Khaled Andrew G. Bulloch Jeanne V. A. Williams Dina H. Lavorato Scott B. Patten Major Depression Is a Risk Factor for Shorter Time to First Cigarette Irrespective of the Number of Cigarettes Smoked Per Day: Evidence From a National Population Health SurveyNicotine Tob Res201113111059671462-2203, 1469-994XOxford University Press (OUP)

13 

Mariam El-Zein Marie-Elise Parent Belinda Nicolau Anita Koushik Jack Siemiatycki Marie-Claude Rousseau Body mass index, lifetime smoking intensity and lung cancer riskInt J Cancer201313371721310020-7136Wiley

14 

Adam Csordas David Bernhard The biology behind the atherothrombotic effects of cigarette smokeNat Rev Cardiol2013104219301759-5002, 1759-5010Springer Science and Business Media LLC

15 

Seppo Juvela Kristiina Poussa Matti Porras Factors Affecting Formation and Growth of Intracranial AneurysmsStroke2001322485910039-2499, 1524-4628Ovid Technologies (Wolters Kluwer Health)

16 

Daan Backes Gabriel J.E. Rinkel Kamil G. Laban Ale Algra Mervyn D.I. Vergouwen Patient- and Aneurysm-Specific Risk Factors for Intracranial Aneurysm GrowthStroke201647495170039-2499, 1524-4628Ovid Technologies (Wolters Kluwer Health)

17 

M.L. Saddleson L.T. Kozlowski G.A. Giovino G.G. Homish M.C. Mahoney M.L. Goniewicz Assessing 30-day quantity-frequency of U.S. adolescent cigarette smoking as a predictor of adult smoking 14 years laterDrug Alcohol Depend20161629280376-8716Elsevier BV

18 

Adam Csordas Simone Kreutmayer Christian Ploner Peter R. Braun Alexander Karlas Aleksandar Backovic Cigarette smoke extract induces prolonged endoplasmic reticulum stress and autophagic cell death in human umbilical vein endothelial cellsCardiovasc Res201192114180008-6363, 1755-3245Oxford University Press (OUP)

19 

Allen L. Ho Ning Lin Kai U. Frerichs Rose Du Smoking and Intracranial Aneurysm MorphologyNeurosurg201577159660148-396XOxford University Press (OUP)

20 

Anil Can Rose Du Association of Hemodynamic Factors With Intracranial Aneurysm Formation and RuptureNeurosurg2016784510200148-396X, 1524-4040Oxford University Press (OUP)

21 

B R Jr J P Broderick Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screeningLancet Neurol2014134393404

22 

Monique H.M. Vlak Gabriel J.E. Rinkel Paut Greebe Johanna G. van der Bom Ale Algra Trigger Factors and Their Attributable Risk for Rupture of Intracranial AneurysmsStroke20114271878820039-2499, 1524-4628Ovid Technologies (Wolters Kluwer Health)

23 

Joshua D. Hughes Milan Samarage Anthony M. Burrows Giuseppe Lanzino Alejandro A. Rabinstein Body Mass Index and Aneurysmal Subarachnoid Hemorrhage: Decreasing Mortality with Increasing Body Mass IndexWorld Neurosurg2015846159816041878-8750Elsevier BV



jats-html.xsl

© 2020 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)